Prostate cancer screening in Switzerland: a literature review and consensus statement from the Swiss Society of Urology
Swiss Medical Weekly · 2024
DOI: 10.57187/s.3626 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Swiss Medical Weekly, 2024. Verfasst von Christoph Würnschimmel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Early Detection of Cancer, Prostate-Specific Antigen, Mass Screening. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Over a decade ago, the United States Preventive Services Taskforce (USPSTF) recommended against prostate-specific antigen (PSA)-based screening for prostate cancer in all men, which considerably influenced prostate cancer screening policies worldwide after that. Consequently, the world has seen increasing numbers of advanced stages and prostate cancer deaths, which later led the USPSTF to withdraw its initial statement. Meanwhile, the European Union has elaborated a directive to address the problem of implementing prostate cancer screening in “Europe’s Beating Cancer Plan”. In Switzerland, concerned urologists formed an open Swiss Prostate Cancer Screening Group to improve the early detection of prostate cancer. On the 20th of September 2023, during the annual general assembly of the Swiss Society of Urology (SGU/SSU) in Lausanne, members positively voted for a stepwise approach to evaluate the feasibility of implementing organised prostate cancer screening programs in Switzerland. The following article will summarise the events and scientific advances in the last decade during which evidence and promising additional modalities to complement PSA-based prostate cancer screening have emerged. It also aims to provide an overview of contemporary strategies and their potential harms and benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
- Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
- Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
- Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.
- Faculty Member, University Hospital Basel, Basel, Switzerland.
- Department of Urology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Zitieren
APA
Würnschimmel, C., Menges, D., Kwiatkowski, M., Sigg, S., Prause, L., Mattei, A., Engeler, D., Eberli, D., Seifert, H., Valerio, M., Rentsch, C. A., & Mortezavi, A. (2024). Prostate cancer screening in Switzerland: a literature review and consensus statement from the Swiss Society of Urology. Swiss Medical Weekly. https://doi.org/10.57187/s.3626
Vancouver
Würnschimmel C, Menges D, Kwiatkowski M, Sigg S, Prause L, Mattei A, et al. Prostate cancer screening in Switzerland: a literature review and consensus statement from the Swiss Society of Urology. Swiss Medical Weekly. 2024. doi:10.57187/s.3626
BibTeX
@article{Wrnschimmel2024,
author = {Würnschimmel, Christoph and Menges, Dominik and Kwiatkowski, Maciej and Sigg, Silvan and Prause, Lukas and Mattei, Agostino and Engeler, Daniel and Eberli, Daniel and Seifert, Helge and Valerio, Massimo and Rentsch, Cyrill A and Mortezavi, Ashkan},
title = {Prostate cancer screening in Switzerland: a literature review and consensus statement from the Swiss Society of Urology},
journal = {Swiss Medical Weekly},
year = {2024},
doi = {10.57187/s.3626}
}
EUVIMED